In addition, ALKBH5, as the second m6A demethylated enzyme discovered after FTO, was reported to promote tumor stem formation in gliomas and promote tumor progression in breast cancer, colon cancer and hepatocellular carcinoma [85, 86]. Here, ALKBH5 is linked to neoplasm.